Abalos Therapeutics has harnessed the unique immune stimulation of the arenavirus to develop a novel anti-cancer approach that provides the full breadth of the immune system’s power specifically against cancer cells. Through viral replication within cancer cells, Abalos’ arenavirus-based drug candidates are designed to awake precise innate and adaptive immune responses and activate all relevant immune cell types against primary tumors and metastases. Led by experienced biotech entrepreneurs and immunology pioneers, Abalos’ goal is to achieve a quantum leap in immuno-oncology.
Company Details
- Employees
- 24
- Address
- Merowingerplatz 1 A, Düsseldorf,nrw 40225,germany
- Phone
- +49 201 565 787-00
- in****@****-tx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- abalos-tx.com
- HQ
- Düsseldorf, NRW
Abalos Therapeutics Gmbh Questions
Abalos Therapeutics Gmbh's helpline number is +49 201 565 787-00
Abalos Therapeutics Gmbh's website is abalos-tx.com
Abalos Therapeutics Gmbh's LinkedIn profile is https://de.linkedin.com/company/abalos-the
Abalos Therapeutics Gmbh has
24 employees.
View email and phone details for 24
employees at Abalos Therapeutics Gmbh.
Abalos Therapeutics Gmbh's industry is
Biotechnology Research
Abalos Therapeutics Gmbh's top competitors are
Priavoid Gmbh,
Plectonic Biotech,
Atriva Therapeutics Gmbh,
Cellex Cell Professionals,
3io Therapeutics,
Evoenzyme,
Ksq Therapeutics, Inc.,
Pfanstiehl, Inc.,
Tubulis Gmbh,
Numaferm.
Abalos Therapeutics Gmbh's support email address is info@abalos-tx.com
Abalos Therapeutics Gmbh's categories are Biotechnology Research
